An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma
Blood and Lymphatic Cancer: Targets and Therapy · 2025-06 · Volume 15 · 11-20
DOI: 10.2147/blctt.s516356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2025-06. Verfasst von Luciano J Costa und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama at Birmingham, Birmingham, AL, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Alabama at Birmingham, Birmingham, AL, USA.
- Duke University School of Medicine, Durham, NC, USA.
- Bethanien Hospital, Frankfurt, Germany.
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- STATLOG Inc, Montreal, QC, Canada.
- Chief Medical Affairs Office, Pfizer Inc, New York, NY, USA.
ORCID-Profile: Marco DiBonaventura
Zitieren
APA
Costa, L. J., LeBlanc, T. W., Tesch, H., Sonneveld, P., Johnson, S. M. A., Vekeman, F., Hlavacek, P., Meche, A., Kim, C. H., Cislo, P., Hughes, D. M., Nador, G., & DiBonaventura, M. (2025). An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma. Blood and Lymphatic Cancer: Targets and Therapy, Volume 15, 11-20. https://doi.org/10.2147/blctt.s516356
Vancouver
Costa LJ, LeBlanc TW, Tesch H, Sonneveld P, Johnson SMA, Vekeman F, et al. An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma. Blood and Lymphatic Cancer: Targets and Therapy. 2025;Volume 15:11-20. doi:10.2147/blctt.s516356
BibTeX
@article{Costa2025,
author = {Costa, Luciano J and LeBlanc, Thomas W and Tesch, Hans and Sonneveld, Pieter and Johnson, Sarasa M A and Vekeman, Francis and Hlavacek, Patrick and Meche, Aster and Kim, Chai Hyun and Cislo, Paul and Hughes, David M and Nador, Guido and DiBonaventura, Marco},
title = {An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2025},
volume = {Volume 15},
pages = {11--20},
doi = {10.2147/blctt.s516356}
}
EUVIMED